Marcie Weil

484 total citations
5 papers, 183 citations indexed

About

Marcie Weil is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marcie Weil has authored 5 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marcie Weil's work include Heat shock proteins research (2 papers), PARP inhibition in cancer therapy (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Marcie Weil is often cited by papers focused on Heat shock proteins research (2 papers), PARP inhibition in cancer therapy (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Marcie Weil collaborates with scholars based in United States, Ukraine and Malaysia. Marcie Weil's co-authors include Alice P. Chen, Shivaani Kummar, Yvonne Horneffer, James H. Doroshow, Lamin Juwara, Giovanna Speranza, Larry Rubinstein, Barbara A. Conley, Jerry M. Collins and Michelle Eugeni and has published in prestigious journals such as Journal of Clinical Oncology, Investigational New Drugs and Current Problems in Cancer.

In The Last Decade

Marcie Weil

5 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcie Weil United States	4	133	93	25	25	17	5	183
Dan Heathcote United Kingdom	6	229 1.7×	105 1.1×	12 0.5×	19 0.8×	12 0.7×	10	363
Martyna Marani United Kingdom	4	172 1.3×	78 0.8×	33 1.3×	24 1.0×	18 1.1×	4	216
Syd Barthorpe United Kingdom	5	141 1.1×	84 0.9×	11 0.4×	10 0.4×	16 0.9×	7	210
Andrew Barthorpe United Kingdom	3	147 1.1×	67 0.7×	18 0.7×	10 0.4×	16 0.9×	3	213
R. Shi China	8	248 1.9×	88 0.9×	24 1.0×	20 0.8×	20 1.2×	12	322
Shiyun Ling United States	5	216 1.6×	128 1.4×	17 0.7×	17 0.7×	11 0.6×	7	280
Robert Kassees United States	3	127 1.0×	74 0.8×	5 0.2×	15 0.6×	20 1.2×	6	162
Thibault Houlès France	9	208 1.6×	88 0.9×	9 0.4×	26 1.0×	26 1.5×	12	296
Ian M. Love United States	9	372 2.8×	142 1.5×	39 1.6×	30 1.2×	15 0.9×	9	417
Nianxin Zhou United States	6	127 1.0×	62 0.7×	53 2.1×	36 1.4×	18 1.1×	7	223

Countries citing papers authored by Marcie Weil

Since Specialization

Citations

This map shows the geographic impact of Marcie Weil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcie Weil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcie Weil more than expected).

Fields of papers citing papers by Marcie Weil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcie Weil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcie Weil. The network helps show where Marcie Weil may publish in the future.

Co-authorship network of co-authors of Marcie Weil

This figure shows the co-authorship network connecting the top 25 collaborators of Marcie Weil. A scholar is included among the top collaborators of Marcie Weil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcie Weil. Marcie Weil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Speranza, Giovanna, Larry Anderson, Alice P. Chen, et al.. (2017). First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile. Investigational New Drugs. 36(2). 230–239. 31 indexed citations

2.

Doroshow, James H., Alice P. Chen, Deborah Allen, et al.. (2012). Proof of mechanism (POM) in the first-in-human trial of two novel indenoisoquinoline, non-camptothecin topoisomerase I (TOP1) inhibitors.. Journal of Clinical Oncology. 30(15_suppl). 3031–3031. 2 indexed citations

3.

Speranza, Giovanna, Robert J. Kinders, Sonny Khin, et al.. (2012). Pharmacodynamic biomarker-driven trial of MK-2206, an AKT inhibitor, with AZD6244 (selumetinib), a MEK inhibitor, in patients with advanced colorectal carcinoma (CRC).. Journal of Clinical Oncology. 30(15_suppl). 3529–3529. 15 indexed citations

4.

Speranza, Giovanna, Alice P. Chen, Jane B. Trepel, et al.. (2012). Phase l study assessing a two-consecutive-day (QD x 2) dosing schedule of the HSP90 inhibitor, AT13387, in patients with advanced solid tumors.. Journal of Clinical Oncology. 30(15_suppl). 3087–3087. 4 indexed citations

5.

Weil, Marcie & Alice P. Chen. (2011). PARP Inhibitor Treatment in Ovarian and Breast Cancer. Current Problems in Cancer. 35(1). 7–50. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact